AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,000 | -81.8% | 146,737 | -0.0% | 0.00% | -100.0% |
Q2 2022 | $22,000 | -15.4% | 146,758 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $26,000 | -63.4% | 146,958 | -1.5% | 0.00% | -60.0% |
Q4 2021 | $71,000 | -60.6% | 149,238 | +15.4% | 0.01% | -61.5% |
Q3 2021 | $180,000 | -49.2% | 129,372 | -49.7% | 0.01% | 0.0% |
Q2 2021 | $354,000 | +47.5% | 257,238 | +99.2% | 0.01% | -35.0% |
Q1 2021 | $240,000 | +6.2% | 129,119 | +2.7% | 0.02% | -4.8% |
Q4 2020 | $226,000 | +227.5% | 125,744 | +52.0% | 0.02% | +162.5% |
Q3 2020 | $69,000 | -4.2% | 82,744 | +34.5% | 0.01% | -11.1% |
Q2 2020 | $72,000 | +157.1% | 61,523 | +19.4% | 0.01% | +125.0% |
Q1 2020 | $28,000 | -9.7% | 51,523 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $31,000 | +55.0% | 51,523 | +17.8% | 0.00% | +33.3% |
Q3 2019 | $20,000 | +42.9% | 43,733 | +29.6% | 0.00% | +50.0% |
Q2 2019 | $14,000 | -22.2% | 33,733 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $18,000 | +63.6% | 33,733 | +47.8% | 0.00% | +50.0% |
Q4 2018 | $11,000 | +10.0% | 22,824 | 0.0% | 0.00% | +100.0% |
Q3 2018 | $10,000 | – | 22,824 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cypress Capital Management LLC (WY) | 234,225 | $132,000 | 0.18% |
Noven Financial Group, Inc. | 123,772 | $70,000 | 0.04% |
Harvest Investment Services, LLC | 109,443 | $60,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 559,489 | $314,000 | 0.03% |
COURIER CAPITAL LLC | 354,973 | $199,000 | 0.03% |
Valeo Financial Advisors, LLC | 330,000 | $185,000 | 0.02% |
Transform Wealth, LLC | 205,481 | $115,000 | 0.02% |
WEDBUSH SECURITIES INC | 326,793 | $184,000 | 0.02% |
STEEL GROVE CAPITAL ADVISORS, LLC | 55,500 | $31,000 | 0.02% |
MONTAG A & ASSOCIATES INC | 230,000 | $129,000 | 0.01% |